InicioBBN • SWX
add
Bellevue Group AG
Cierre anterior
14,75 CHF
Intervalo diario
14,50 CHF - 14,80 CHF
Intervalo anual
11,05 CHF - 24,30 CHF
Cap. bursátil
195,19 M CHF
Volumen medio
9,95 mil
Relación precio-beneficio
13,08
Rentabilidad por dividendo
7,93 %
Bolsa de valores principal
SWX
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
(CHF) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos | 18,41 M | -11,31 % |
Gastos operativos | 13,73 M | -10,56 % |
Ingresos netos | 3,72 M | -7,22 % |
Margen de beneficio neto | 20,18 | 4,61 % |
Beneficios por acción | — | — |
EBITDA | — | — |
Tipo impositivo efectivo | 17,26 % | — |
Balance general
Activos totales
Responsabilidades totales
(CHF) | jun 2024info | Cambio interanual |
---|---|---|
Efectivo y a corto plazo | 30,49 M | 100,63 % |
Activos totales | 138,75 M | -4,69 % |
Responsabilidades totales | 22,05 M | -24,81 % |
Patrimonio total | 116,70 M | — |
Acciones en circulación | 13,20 M | — |
Precio-valor contable | 1,67 | — |
Rentabilidad económica | 10,71 % | — |
Retorno sobre capital | — | — |
Flujo de caja
Variación neta del flujo de caja
(CHF) | jun 2024info | Cambio interanual |
---|---|---|
Ingresos netos | 3,72 M | -7,22 % |
Efectivo de operaciones | 3,65 M | 137,31 % |
Efectivo de inversión | — | — |
Efectivo de financiación | -8,10 M | 45,85 % |
Variación neta del flujo de caja | -4,17 M | 83,13 % |
Flujo de caja libre | — | — |
Información sobre la empresa
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Director ejecutivo
Fundación
1993
Sitio web
Empleados
88